Evaluating cost-effectiveness in the management of neuroendocrine neoplasms

por White, B. E., Mujica-Mota, R., Snowsill, T., Gamper, E. M., Srirajaskanthan, R., Ramage, J. K.
Publicado 2020

ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours

por Srirajaskanthan, Rajaventhan, Ahmed, A., Prachialias, A., Srinivasan, P., Heaton, N., Jervis, N., Quaglia, A., Vivian, G., Ramage, J. K.
Publicado 2013

Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21

por Friend, E, Yadegarfar, G, Byrne, C, Johnson, C D, Sezer, O, Pucciarelli, S, Pereira, S P, Chie, W-C, Banfield, A, Ramage, J K
Publicado 2011

Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours

por Yadegarfar, G, Friend, L, Jones, L, Plum, L M, Ardill, J, Taal, B, Larsson, G, Jeziorski, K, Kwekkeboom, D, Ramage, J K
Publicado 2013

Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder

por Kaupp-Roberts, S D, Yadegarfar, G, Friend, E, O'Donnell, C M, Valle, J W, Byrne, C, Bahar, I, Finch-Jones, M, Gillmore, R, Johnson, C D, Pereira, S P, Wiggers, J K, Pinto, M, Al-Sarireh, B, Ramage, J K
Publicado 2016